195
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Effects of MTHFR c.677C>T, F2 c.20210G>A and F5 Leiden Polymorphisms in Gastroschisis

, , , , &
Pages 88-92 | Received 19 May 2015, Accepted 27 Jul 2015, Published online: 16 Sep 2015

REFERENCES

  • Mastroiacovo P, Lisi A, Castilla E, et al. Gastroschisis and associated defects: an international study. Am J Med Genet A. 2007;143A:660–671.
  • Kirby RS, Marshall J, Tanner JP, et al. Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005. Obstet Gynecol. 2013;122:275–281.
  • Parker SE, Mai CT, Canfield MA, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol. 2010;88:1008–1016.
  • Ledbetter DJ. Gastroschisis and omphalocele. Surg Clin North Am. 2006;86:249–260.
  • Williams LJ, Kucik CJ, Olney RS, et al. Epidemiology of gastroschisis in metropolitan Atlanta, 1968 through 2000. Birth Defects Res A Clin Mol Teratol. 2005;73:177–183.
  • Hwang PJ, Kousseff BG. Omphalocele and gastroschisis: an 18-year review study. Genet Med. 2004;6:232–236.
  • Salihu HM, Pierre-Louis BJ, Druschel CM, et al. Omphalocele and gastroschisis in the state of New York, 1992–1999. Birth Defects Res A Clin Mol Teratol. 2003;67:630–636.
  • Lubinsky M. A vascular and thrombotic model of gastrochisis. Am J Med Genet A. 2014;164A:915–917.
  • Cardonick E, Broth R, Kaufmann M, et al. Genetic predispositions for thromboembolism as a possible etiology for gastroschisis. Am J Obstet Gynecol. 2005;193:426–428.
  • Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–1155.
  • Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the F2 gene is associated with elevated plasma F2 levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703.
  • Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67.
  • Ağaoğlu N, Mustafa NA, Türkyilmaz S. Prothrombotic disorders in patients with mesenteric vein thrombosis. J Invest Surg. 2003;16:299–304.
  • Torfs CP, Christianson RE, Iovannisci DM, et al. Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis. Birth Defects Res A Clin Mol Teratol. 2006;76:723–730.
  • The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–1073.
  • Parveen F, Shukla A, Agrawal S. Should factor V Leiden mutation and F2 gene polymorphism testing be done in women with recurrent miscarriage from North India? Arch Gynecol Obstet. 2013;287:375–381.
  • Basaran O, Atac FB, Karakayali F, et al. Endothelial nitric oxide synthase gene intron 4 (VNTR) polymorphism and vascular access graft thrombosis. J Invest Surg. 2007;20:49–53.
  • Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in the methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113.
  • Emison ES, Garcia-Barcelo M, Grice EA, et al. Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet. 2010;87:60–74.
  • Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81: 559–575.
  • Li XM, Wei YF, Hao HL, et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd–Chiari syndrome. Am J Hematol. 2002;71:11–14.
  • Yang B, Liu Y, Li Y, et al. Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of Han nationality. PLoS One. 2013;8:e57917.
  • Dajani R, Arafat A, Hakooz N, et al. Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan. J Thromb Thrombolysis. 2013;35:83–89.
  • Garcia-Barcelo MM, Tang CS, Ngan ES, et al. Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease. Proc Natl Acad Sci USA. 2009;106:2694–2699.
  • Phusantisampan T, Sangkhathat S, Phongdara A, et al. Association of genetic polymorphisms in the RET protooncogene and NRG1 with Hirschsprung disease in Thai patients. J Hum Genet. 2012;57:286–293.
  • Gunadi Kapoor A, Ling AY, Rochadi Makhmudi A, et al. Effects of RET and NRG1 polymorphisms in Indonesian patients with Hirschsprung disease. J Pediatr Surg. 2014;49:1614–1618.
  • Kapoor A, Jiang Q, Chatterjee S, et al. Population variation in total genetic risk of Hirschsprung disease from common RET, SEMA3 and NRG1 susceptibility polymorphisms. Hum Mol Genet. 2015;24:2997–3003.
  • Luzon-Toro B, Torroglosa A, Nunez-Torres R, et al. Comprehensive analysis of NRG1 common and rare variants in Hirschsprung patients. PLoS One. 2012;7:e36524.
  • Bailey LB, Gregory 3rd JF. Folate metabolism and requirements. J Nutr. 1999;129:779–782.
  • Nelen WL, Bulten J, Steegers EA, et al. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000;15:954–960.
  • Loane M, Dolk H, Bradbury I. Increasing prevalence of gastroschisis in Europe 1980–2002: A phenomenon restricted to younger mothers? Paediatr Perinatal Epidemiol. 2007;21:363–369.
  • Jenkins MM, Reefhuis J, Gallagher ML, et al. Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk. Am J Med Genet A. 2014;164A(6):1454–63.
  • Skarsgard ED, Meaney C, Bassil K, et al. Maternal risk factors for gastroschisis in Canada. Birth Defects Res A Clin Mol Teratol. 2015;103(2):111–8.
  • Agopian AJ, Langlois PH, Cai Y, et al. Maternal residential atrazine exposure and gastroschisis by maternal age. Matern Child Health J. 2013;17(10):1768–75.
  • Khodr ZG, Lupo PJ, Canfield MA, et al. Hispanic ethnicity and acculturation, maternal age and the risk of gastroschisis in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2013;97(8):538–45.
  • Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem. 1997;43:1678–1683.
  • Zivelin A, Griffin JH, Xu X, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood. 1997;89:397–402.
  • Rosendaal FR, Doggen CJM, Zivelin A, et al. Geographic distribution of the 20210 G to A F2 variant. Thromb Haemost. 1998;79:706–708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.